title: Pure red cell aplasia after 13 years of sodium valproate, and bone marrow suppression after 17 years of carbamazepine.
authors.affiliation: Saint Peter's University Hospital, New Brunswick, New Jersey, USA. tionggthe@pol.net
authors.forename: Tiong
authors.initials: T
authors.lastname: The
authors.forename: Ratnavalli
authors.initials: R
authors.lastname: Kolla
authors.forename: Fitzroy
authors.initials: F
authors.lastname: Dawkins
authors.forename: Annapurni Jayam
authors.initials: AJ
authors.lastname: Trouth
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects / Q000502:physiology; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004314:Down Syndrome; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D013997:Time Factors; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D014635:Valproic Acid